CVE vs VET

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

CVE

63.1
AI Score
VS
VET Wins

VET

66.3
AI Score

Investment Advisor Scores

CVE

63score
Recommendation
STRONG BUY

VET

66score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CVE VET Winner
Forward P/E 7.8309 17.3611 CVE
PEG Ratio 0.45 3.58 CVE
Revenue Growth 21.1% 30.4% VET
Earnings Growth 155.0% -94.9% CVE
Tradestie Score 63.1/100 66.3/100 VET
Profit Margin 15.4% -24.6% CVE
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD CVE

Relative Price Performance (Last 90 Days)

CVE 1M: -13.5% · 3M: -7.2% VET 1M: -13.1% · 3M: -5.3%

Current Technical Phase

CVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.1%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $28.41

VET

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.5 · Price: $10.64

Fundamentals Snapshot

Metric CVE VET
Market Cap — —
Forward P/E 8.0 5.1
Trailing P/E 8.2 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.3%
Gross Margin 0.3% 0.6%
Operating Margin 0.3% -0.2%
EPS 3.39 -2.26
Dividend Yield 0.03% 0.05%

Frequently Asked Questions

Based on our detailed analysis, VET is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.